4,500 participants from Canada, the United States, Europe, South America, and South Africa participated in the international study, which included patients who had at least one risk of coronary entrapment. Participants, who were diagnosed as validated by a pen test, received a 0.5 mg colchicine pill twice a day for three days, and then took one pill for 27 days. In contrast, in the control group, they received a placebo for 30 days.
He added: “Beyond the effectiveness of the Corona drug in Corona, which is to be welcomed, the study shows the need for government donations for studies to change the labels of generic drugs that no commercial entities are interested in making. The interest in effective community care is clearly needed. “Israel will allocate resources to this – to save the lives of Corona patients and prevent the collapse of the hospital system.”